Related Experiment Video
Updated: Jun 26, 2026

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
New theophylline-activated Diels-Alderase ribozymes by molecular engineering
Markus Petermeier1, Andres Jäschke
1Institute of Pharmacy and Molecular Biotechnology, University of Heidelberg, Im Neuenheimer Feld 364, D-69120, Heidelberg, Germany.
Abstract:
Allosteric ribozymes were developed by rational design and step-wise optimization. These ribozymes accelerate a Diels-Alder reaction between anthracene and maleimide derivatives. The optimized sequence is efficiently activated by theophylline under single and multiple turnover conditions and distinguishes between structurally similar effector molecules.
More Related Videos
Related Concept Videos
Ribozymes
Ribozymes can be...
Ribozymes
Ribozymes can be...
Diels–Alder Reaction: Characteristics of Dienophiles
Characteristics of Dienophiles
Generally, the best dienophiles are alkenes containing electron-withdrawing substituents such as carbonyl, nitrile, and nitro groups. The feasibility of a Diels–Alder reaction depends on...
Diels–Alder Reaction Forming Cyclic Products: Stereochemistry
Oxidation of Alkenes: Syn Dihydroxylation with Osmium Tetraoxide
[4+2] Cycloaddition of Conjugated Dienes: Diels–Alder Reaction

